BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22398971)

  • 1. Advances in imaging to support the development of novel therapies for multiple sclerosis.
    Miller DH; Altmann DR; Chard DT
    Clin Pharmacol Ther; 2012 Apr; 91(4):621-34. PubMed ID: 22398971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
    Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging in multiple sclerosis.
    Miller DH; McDonald WI
    Clin Neurosci; 1994; 2(3-4):215-24. PubMed ID: 7749891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic neuritis.
    Toosy AT; Mason DF; Miller DH
    Lancet Neurol; 2014 Jan; 13(1):83-99. PubMed ID: 24331795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis.
    Costello FE; Klistorner A; Kardon R
    Ophthalmic Surg Lasers Imaging; 2011 Jul; 42 Suppl():S28-40. PubMed ID: 21790109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future potential of retinal optical coherence tomography in multiple sclerosis with and without optic neuritis.
    Balk LJ; Petzold A
    Neurodegener Dis Manag; 2014; 4(2):165-76. PubMed ID: 24832034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
    Sepulcre J; Murie-Fernandez M; Salinas-Alaman A; GarcĂ­a-Layana A; Bejarano B; Villoslada P
    Neurology; 2007 May; 68(18):1488-94. PubMed ID: 17470751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonconventional optic nerve imaging in multiple sclerosis.
    Glisson CC; Galetta SL
    Neuroimaging Clin N Am; 2009 Feb; 19(1):71-9. PubMed ID: 19064201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early diagnosis, monitoring, and treatment of optic neuritis.
    Chan JW
    Neurologist; 2012 Jan; 18(1):23-31. PubMed ID: 22217611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis. Part I: neuro-ophthalmic manifestations.
    Pula JH; Reder AT
    Curr Opin Ophthalmol; 2009 Nov; 20(6):467-75. PubMed ID: 19809319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis.
    Watson GM; Keltner JL; Chin EK; Harvey D; Nguyen A; Park SS
    J Neuroophthalmol; 2011 Jun; 31(2):110-6. PubMed ID: 21131852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optic neuritis.
    Clark D; Kebede W; Eggenberger E
    Neurol Clin; 2010 Aug; 28(3):573-80. PubMed ID: 20637989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
    Bonhomme GR; Waldman AT; Balcer LJ; Daniels AB; Tennekoon GI; Forman S; Galetta SL; Liu GT
    Neurology; 2009 Mar; 72(10):881-5. PubMed ID: 19273821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunotherapy of multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials].
    Ozawa K; Saida T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1501-3. PubMed ID: 8752444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes.
    Zipp F
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S24-9. PubMed ID: 20106345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
    Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH
    Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of optical coherence tomography in multiple sclerosis: expert panel consensus.
    Sergott RC; Frohman E; Glanzman R; Al-Sabbagh A;
    J Neurol Sci; 2007 Dec; 263(1-2):3-14. PubMed ID: 17673257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNFL thickness in MS-associated acute optic neuritis using SD-OCT: critical interpretation and limitations.
    Serbecic N; Beutelspacher SC; Geitzenauer W; Kircher K; Lassmann H; Reitner A; Khan A; Schmidt-Erfurth U
    Acta Ophthalmol; 2011 Aug; 89(5):e451-60. PubMed ID: 21401908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis and the ophthalmologist.
    Mowry EM; Balcer LJ; Galetta SL
    Compr Ophthalmol Update; 2007; 8(1):39-49. PubMed ID: 17394758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.